RVT-1401, A Novel Anti-FcRn Monoclonal Antibody, Is Well Tolerated in Healthy Subjects and Reduces Plasma IgG Following Subcutaneous or Intravenous Administration (P5.2-079)
用户wxb8loTerxGI
2小时前
6
10
求助中
帖子自动结束时间: 2026-04-05 14:51:19
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性，不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1212/wnl.92.15_supplement.p5.2-079
文献链接: https://www.neurology.org/doi/10.1212/WNL.92.15_supplement.P5.2-079
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Jon Collins; Lori Jones; Michele Snyder; Eric Sicard; Paul Griffin; Lindsey Webster; Regan Fong; Christine Coquery; Stephen Piscitelli
